Aditxt Inc.

ADTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.25

-$0.26 (-51.45%)

At close: May 26, 2026, 4:00 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-51.45%

(1D)

Rating

Updated: May 19, 2026

15.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $8.53K

1D Range

0.23 0.36

52W Range

0.23 53,454

Valuation (TTM)

PE 0

PB -0.00

EV/EBITDA -0.10

Valuation (NTM)

Forward PE N/A

Forward PEG N/A

Price Target $1,280

Cash Flow

FCF Yield -217921.4%

SBC Adj. FCF Yield -5769839.3%

SBC Impact -2547.7%

Margins

Gross Margin 19.9%

Operating Margin -127821.4%

FCF Margin -129588.5%

Growth (CAGR)

Revenue 3Y | 5Y -84.9% | N/A

Dil EPS 3Y | 5Y N/A | N/A

FCF 3Y | 5Y -37610.4% | -69523.8%

Returns

ROA -373.6%

ROE 926.0%

ROIC -406.3%

Financial Health

Net Debt

$3.96M

Current Ratio 0.06

Interest Coverage -8.80

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to...

Sector Healthcare

Industry Biotechnology

Employees 26

IPO Date Jun 29, 2020

Website www.aditxt.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Latest Earnings

May 20, 2026

EPS

-$2.06

Beat +100.00%

YoY: +97.22%

REV

$12.16K

Miss -98.78%

YoY: +1094.40%

Next Earnings

Sep 2, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞